Articles By Marcus Johnson

  1. Computers Quicken Pace Of Drug Development And Lower Costs 2/26/2014

    Kun-Yi Hsin is a researcher working with the Open Biology Unit in order to solve problems related to the high cost of developing pharmaceutical drugs.

  2. Indian Lichens Might Help Develop Breast Cancer Drug 2/26/2014

    Lichens located in the northeast region of India might have potential to fight against breast cancer.

  3. Osteoporosis Drug Being Used To Fight Certain Cancers 2/26/2014

    Evista, which was developed and is marketed by drug industry giant Eli Lilly and Co., has shown potential as a treatment for certain cancers, such as breast cancer and liver cancer.

  4. Anti-Epilepsy Drug Could Help Drinkers Curb Habit 2/21/2014

    A drug that is currently being used to treat epilepsy has shown promise in helping drinkers consume less alcohol.

  5. Moran Eye Center Partners With Drug Company Allergan Inc. 2/21/2014

    The Moran Eye Center, which operates as part of the University of Utah, has announced that it will enter into a partnership with pharmaceutical giant Allergan, based out of California.

  6. Scripps Researchers Find New Drug Resistance Mechanism For Antibiotics 2/21/2014

    Researchers at Scripps Research Institute (TSRI) in Florida have found a new way for drugs to resist the constant mutation of bacteria and continue to remain effective.

  7. New German Regulation Could Harm Pharmaceutical Companies 2/21/2014

    Germany is planning new regulation that could have a negative effect on pharmaceutical companies. The nation has plans to make public price discounts that drug companies agreed on with the German government. Drug companies have already complained that such a move could affect their profits across the globe and depress prices in other markets.

  8. NIH Awards Researchers $3 Million For Cancer Related Research 2/21/2014

    The National Institute of Health (NIH) has awarded researchers at Penn State and the University of Texas Southwestern Medical Center $3 million in order to study new polymers, which will be used for a more efficient delivery for targeted cancer drugs.

  9. Type 2 Diabetes Drugs Euro Market To Grow 3.8% Per Year 2/19/2014

    A new report from Frost & Sullivan (F&S) forecasts a 3.8% growth every year for the European market of Type 2 diabetes from a value of 9.50 billion euros in 2009 to 15.46 billion euros in 2017.

  10. Autism Drug Studied On Animals Has Potential For Humans 2/19/2014

    Bumetanide is a drug approved for the treatment of heart and liver disease. It is now being repurposed to treat autism and researchers are in the first stages of studying the drug.